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The use and effectiveness of telehealth to support the management of severe mental 
illness: A systematic review 
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Abstract 
Background: It is important that people with SMI receive early interventions to prevent mental 
health deterioration or relapse.  Telecommunications and other technologies are increasingly used 
to assist healthcare delivery (‘telehealth’), providing service users with immediate real-time 
information to improve the management of chronic health conditions. Telehealth has been found to 
be successful in improving management and symptoms across a number of health conditions, whilst 
also being acceptable to users. Initial findings suggest technology could improve quality of life in 
people with SMI. 
Objectives: This systematic review aimed to identify the variety of uses and efficacy of telehealth 
technology for SMI.  
Methods: We systematically searched electronic databases from inception to March 2016 
(MEDLINE, EMBASE, PsycINFO, Cochrane Central Register of Controlled Trials, AMED, Health 
Technology Assessment, CINAHL plus and NHS EED) for randomised controlled trials (RCTs) 
evaluating telehealth for adults with SMI, published in English. Additional literature was identified by 
searching reference lists of key articles. The articles meeting the inclusion criteria were 
systematically reviewed and assessed for quality and risk of bias.  
Results: The search identified 31 eligible articles, describing 29 trials. The included studies evaluated 
the use of computers to deliver cognitive rehabilitation (15 trials), patient education (3 trials), online 
self-management interventions (2 trials), and to support consultations (1 trial). Virtual reality (VR) 
was used to simulate work and social situations (2 trials) and to deliver cognitive training (1 trial). 
Telephones were used to prompt medication use (3 trials) and report SMI symptoms to healthcare 
teams (1 trial). Remote sensors were used to monitor medication use (1 trial). Telephone support 
was found effective for improving medication adherence and reducing symptom severity and 
inpatient days. Computer assisted cognitive rehabilitation was effective in improving cognitive 
function. The impact of telehealth on other outcomes was inconsistent. Few studies evaluated the 
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use of remote medication telemonitoring, VR, online self-management and computer-mediated 
consultations, suggesting these are novel technologies for managing SMI, although all were found 
effective for improving psychosocial and behavioural outcomes. The results of this review should be 
taken in the context of varied quality in study design, with only five studies demonstrating a low risk 
of bias. 
Conclusions: A growing variety of telehealth technologies are used to support SMI. Specific types of 
technology have been found to be effective for some outcomes, for example telephone prompts for 
medication adherence, while other types of telehealth had no benefit over traditional methods and 
were less acceptable to patients. Few studies found benefits for telehealth on quality of life, except 
for novel technologies with a limited number of trials. Further research is warranted to establish the 
full potential benefits of telehealth for improving quality of life in SMI, acceptability from the service 
user perspective, and cost-effectiveness.  
Keywords:  
Severe mental illness, telehealth, technology, systematic review 
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Introduction 
Telecommunications and other technologies are increasingly being used to assist in healthcare 
delivery and are collectively known as “telehealth”. Telehealth is broadly defined as the use of 
applications in healthcare including telephones, mobile phones, computers, the internet and audio 
and video processing to provide service users with immediate real-time information aimed at 
enhancing the management of their condition or its symptoms [1-3]. Telehealth has been found to 
be effective for managing a range of long-term conditions, including respiratory and cardiac diseases 
and diabetes [4-7]. Benefits include reductions in health service use [4-7], including hospitalization 
and emergency department visits, and improving clinical outcomes [4;7], for example glycemic 
control in people with diabetes [4]. Some initial evidence also suggests that technology is found to 
be acceptable by users to support health management, particularly in terms of convenience [8]. 
While studies measuring the acceptability of using technology to support healthcare are still 
emerging, a review by Or & Karsh [9] identified specific factors that predict acceptability of 
telehealth for long-term conditions, including younger age, higher levels of education, prior 
experience, perceived usefulness and ease of use, and satisfaction [9].  
Severe mental illness (SMI) is commonly defined by persistent and extensive functional disability 
[10] and includes psychotic disorder, schizophrenia, schizoaffective disorder, major depressive 
disorder and bipolar disorder. Previous systematic reviews have evaluated either the use of one 
specific type of telehealth, for example telephone prompts to promote appointment attendance [11; 
12], or the use of telehealth more broadly in a specific mental illness. Some initial findings suggest 
technology-based prompts could improve quality of life and SMI symptoms in people with SMI, 
however the quality of the evidence has been found to be low [12]. Furthermore the review of 
telephone prompts was published in 2009 and given the rise in use of technology and updated 
review is due. Two reviews evaluated a range of applications for general mental health, including 
dementia, child psychiatry, suicide prevention, substance misuse and psychotic disorders [13;14] and 
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found evidence for benefits to mood, trauma-related symptoms and suicide attempts, and better 
medication adherence. However, there does not exist a review of the range of available telehealth 
technologies and their use to support people with SMI. Given the current multitude of available 
telehealth technologies and the rapid increase in their use, a further review is required to identify 
the range of uses for telehealth in the context of SMI and whether they lead to increased service 
user engagement and improved psychological and clinical outcomes across SMIs.  
The aims of this review are to: 1. Identify and describe how telehealth interventions for people with 
SMI have been implemented to date and 2. To synthesise the evidence in relation to the 
effectiveness or efficacy of available interventions.  
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Methods 
Study eligibility 
Studies were selected for inclusion in the review if they met the following criteria: 
1. Types of participants 
Adults aged 18 years or over with SMI defined as psychotic disorder, schizophrenia, schizoaffective 
disorder, major depressive disorder and bipolar disorder as defined by Johnson [10], however 
diagnosed.  If studies included service users with and without SMI only data that could be extracted 
for those with SMI were included. Studies for which it was unclear whether participants in a 
population of “young people” were aged 18 years or over were not included.  
2. Types of studies 
Randomised controlled trials (RCTs) available in English language.  
3. Types of interventions 
Interventions that used telehealth technology targeted to improve the management of SMI.  
4. Outcome measures 
Articles measuring the following outcome measures were considered for this review:  
(1) General or disease specific psychological or psychosocial outcomes, including quality of life 
or mood, using generic or disease-specific validated tools. 
(2) Clinical outcomes including reduction in psychotic symptoms, introduction of new 
antipsychotics, increased intensity of medication, hospital re-admission, mortality rates, 
progression of SMI.  
(3) Attendance as an outpatient or in primary care. 
(4) Adherence to treatment, including medication or recommended psychological support. 
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Studies were excluded if: SMI was caused by dementia or brain injury, they were not available in 
English, they investigated telecare or social care technology such as remote sensors for falls, the 
intervention focused on carers or healthcare professionals rather than service users, participants 
were not randomised, technology was not the primary focus of the intervention, participants had 
major depressive disorder (MDD) or other mood disorders without psychosis.  
Search strategy 
Electronic searches using the following databases were conducted from inception to March 2016: 
MEDLINE, EMBASE, PsycINFO, Cochrane Central Register of Controlled Trials, Allied and 
Complimentary Medicine Database (AMED), Health Technology Assessment (HTA), CINAHL plus with 
full text via EBSCOHost, NHS Economics Evaluations Database (NHS EED) by searching ‘all fields’ 
using the following search terms: TELEHEALTH, TELE*, TECHNOLOGY, E?HEALTH, M?HEALTH, 
ONLINE, WEB*, INTERNET, COMPUTER, MOBILE, APP, VIRTUAL CONSULTATION, PHONE, POCKET PC, 
IPHONE, SHORT MESSAGE SERVICE, SMS, TEXT MESSAG*, WIRELESS, SMARTPHONE, REAL-TIME, 
ELECTRONIC DIAR* and INTERVENTION, PROGRAM*, THERAPY, SUPPORT, EDUCATION, TRAINING 
and SEVERE MENTAL ILLNESS, MENTAL DISORDER, PSYCHOTIC DISORDER, MOOD, AFFECTIVE 
DISRODER, PERSONALITY DISORDER, BIPOLAR DISORDER, SCHZOPHRENIA, DEPRESSION, 
SCHIZOAFFECTIVE DISORDER and RANDOMI?ED, TRIAL, CLINICAL TRIAL, COMPARATIVE STUDY, 
SYSTEMATIC REVIEW, META-ANALYSIS, REVIEW, CROSSOVER PROCEDURE, DOUBLE BLIND*, SINGLE 
BLIND*.  
The first author checked titles and all three authors reviewed abstracts to exclude any irrelevant 
articles. Full-texts of the remaining articles were obtained; all three authors screened these. Any 
disagreements were discussed within the research team to reach consensus.  
References were searched for additional papers.  
Data extraction and management 
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The first author extracted data using a standardised form developed by the Cochrane Collaboration 
[15], which included information on the following: study characteristics (including aim and design), 
participants (including population description, inclusion and exclusion criteria and baseline 
imbalances), features of the intervention and comparison groups (including description, timing and 
providers), outcome measures, statistical methods used in analysis, results, and conclusions.  
Risk of bias 
The Cochrane Collaboration’s tool to assess risk of bias in RCTs [16] was used. The Cochrane risk of 
bias tool includes a list of potential sources of bias in clinical trials, in seven main areas: random 
sequence generation, allocation concealment, blinding of participants and personnel, blinding of 
outcome assessment, incomplete outcome data, selective reporting, and other bias [16]. The rating 
scale for each area of bias ranges from ‘low risk of bias’ to ‘high risk of bias’, and an option of 
‘unclear risk of bias’ for studies that do not provide enough detail to be able to make a clear 
judgement [16]. Two of the review authors (SW, KM) independently judged each article for risk of 
bias, discussing disagreements until a consensus was reached.  
9 
 
Results 
Electronic searches identified 13,907 unique articles and reference searches of key articles identified 
a further 17 potentially eligible articles. Thirty-one articles were found to meet the inclusion criteria, 
which have been presented in a PRISMA [17] diagram (Figure 1). A meta-analysis was not performed 
due to the heterogeneity of the interventions, including their methods of delivery and the outcome 
measures of the included studies. The characteristics of the final 31 articles can be seen in Table 1.  
Table 1. Participant characteristics of the included studies 
First author, 
country of origin, 
year, design, 
length of follow-up 
Population, setting, 
total number 
randomised 
Participant demographics Illness severity 
Beebe, USA, 2008, 
RCT, 12 weeks 
Adults with 
schizophrenia from 
a community 
mental health 
centre, 29; 
Telephone 
intervention 
problem solving 
(TIPS) = 15, TAU = 
14. 
Male (n, %) Intervention = 7 (54), TAU = 8 
(67); Age (not separated by group) 52 years 
(range 25 to 69); Caucasian (n, %) TIPS = 8 
(62), TAU = 8; African American (n, %) TIPS = 
5 (38), TAU = 6 (50); Oral atypicals (n, %) 
TIPS = 10 (77), TAU = 9 (75), Depot typicals 
(n, %) TIPS = 4 (31), TAU = 1 (8), 
Antidepressants (n, %) TIPS = 7 (54), TAU = 4 
(33), Antianxiety agents (n, %) TIPS = 3 (23), 
TAU = 5 (42), Antiparkinsonians (n, %) TIPS= 
5 (38), TAU = 2 (17), Hypnotics (n, %) TIPS = 
2 (15), TAU = 3 (25) 
Not reported 
Bellucci, USA, 2002, 
RCT, 8 weeks 
Adults with 
schizoaffective 
disorder or 
schizophrenia, 34; 
CACR = 17, control 
= 17  
Characteristics not separated by group. Age 
(mean) 42; Male (n, %) 16 (47.1%); An 
average of 3.1 psychiatric medications 
SANS summary 
score: mean (SD) 
CACR = 13.7 (3.6) 
Control = 13.1 (3.8) 
Benedict, USA, 
1994, RCT, follow-
up not reported 
Adults with chronic 
schizophrenia from 
an outpatient day 
treatment centre, 
38; CACR= 16, TAU 
= 17 
Male (n) Experimental = 8, Control = 9; Age 
(mean, SD) Experimental = 38.1 (11.6), 
Control = 39.5 (11.1); White/black 
Experimental = 14/2, Control = 15/2; Days 
hospitalized (mean, SD) Experimental = 
269.0 (211.8), Control = 173.8 (200.7); 
Chlorpromazine equivalents 
(mean, SD) Experimental = 279.7 (196.6), 
Control = 346.1 (544.1); Benzotropine 
equivalents (mean, SD) Experimental = 2.8 
(2.2), Control = 3.1 (2.7) 
 
SANS (mean, SD) 
Experimental = 11.7 
(3.5), Control = 11.7 
(3.9); SAPS (mean, 
SD) Experimental = 
9.6 (2.9), Control = 
8.4 (3.3) 
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Burda, USA, 1994, 
RCT, 8 weeks 
Adult inpatients 
with schizophrenia 
or schizoaffective 
disorder in a 
medical centre, 69; 
CACR= 40, control = 
29 
Age (mean, SD) Experimental = 50 (12.51), 
control = 41.97 (8.16); Diagnosis (not 
separated by group): undifferentiated type 
schizophrenia (n=24), paranoid type 
schizophrenia (n=23), schizoaffective 
(n=22);  
Not reported 
Cavallaro, Italy, 
2009, RCT, 12 
weeks 
Adults with 
schizophrenia at 
two psychiatric care 
centres, 100; CACR 
= 50, control = 50 
Age (mean, SD) Experimental = 33.2 (9.5), 
Control = 34.2 (6.8);  Illness duration in 
years (mean, SD) Experimental = 8.28 (6.7), 
Control = 8.08 (5.1) 
PANSS-positive 
SRT+CRT = 10.8 
(3.8) SRT+PBO = 
10.05 (3.6); PANSS-
negative SRT+CRT = 
13.7 (4.5) SRT+PBO 
= 14.6 (4.3) 
Chan, Hong Kong, 
2010, RCT, 10 
weeks 
Older adults with 
chronic 
schizophrenia from 
a residential care 
setting, 29; VR = 14, 
Control = 15 
Male (n, %) VR = 10 (83.3), Control = 8 
(53.3); Age (mean, SD) VR = 66.4 (6.2), 
Control = 65.87 (5.54) 
Not reported 
D’Amato, France, 
2011, RCT, 12 
weeks 
Adults inpatients 
with schizophrenia, 
77; CACR = 39, 
control = 38 
Male (n) CRT = 29, Non-CRT = 29; Age 
(mean, SD) CRT = 33.4 (6.9), Non-CRT = 32.2 
(6.0) 
PANSS CRT = 73.3 
(11.6) Non-CRT = 
75.7 (13.0) 
Dickinson, USA, 
2010, RCT, 12 
weeks 
Adults with 
schizophrenia or 
schizoaffective 
disorder attending 
a Veterans 
Integrated Services 
Network, and 
community 
psychiatry clinics, 
67; CACR = 35, 
control = 32 
 
All participants were diagnosed with 
schizophrenia or schizoaffective disorder 
using the Structured Clinical Interview for 
DSM-IV (SCID), information from the 
participants’ mental health care providers, 
and medical records; Male n (%) 
Remediation = 23 (65.7), Control = 21 
(75.0); Age (mean, SD) Remediation = 46.9 
(6.6), Control = 48.5 (8.8); African American 
n (%) Remediation = 23 (65.7), Control = 15 
(53.6); Receiving second-generation 
antipsychotic (versus low-dose first-
generation antipsychotic or other) n (%) 
Remediation = 26 (74.3), Control = 19 (67.9) 
SANS score (mean, 
SD) Remediation = 
23.60 (8.32), 
Control = 27.11 
(11.98) 
Frangou, UK, 2005, 
RCT, 8 weeks 
Adults with 
schizophrenia 
attending 
outpatient clinics, 
108; @HOME = 36, 
TAU = 36, Pill 
counting group = 36 
Male (n) Routine care = 13, Pill counting = 7, 
@HOME = 5; Age (mean, SD) Routine care = 
47.2 (9.8), Pill counting = 49.6 (11.6), 
@HOME = 45.5 (9.6); Hospitalisations in 
previous 12 months (mean, SD) Routine 
care = 4.3 (5.9), Pill counting = 3.6 (2.7), 
@HOME = 2.8 (2.5) 
PANSS (mean, SD) 
Routine care = 46.6 
(15.9) Pill counting 
= 43.4 (15.5) 
@HOME = 43 (14.9) 
Hansson, 
Multicentre (Spain, 
The Netherlands, 
UK, Sweden, 
Germany & 
Switzerland), 2008, 
Adults with 
schizophrenia on 
caseloads of 
participating key 
workers, 507; 
DIALOG = 271, TAU 
Female (%) Intervention = 32.5, TAU = 35.2; 
Age (mean, SD) Intervention = 42.5 (11.3), 
TAU = 41.8 (11.6); Duration of illness (yr) 
Intervention = 15.2 (9.9) TAU = 16.6 (10.5) 
 
 
PANSS (mean, SD) 
Intervention = 62.2 
(17.4) TAU = 64.8 
(19.8) 
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RCT, 12 months = 236  
Hermanutz, 
Germany, 1991, 
RCT, 4 weeks 
Adults with 
schizophrenia on 
admission wards, 
30; CACR = 10, 
control = 10, "0" 
group = 10 
All participants were treated with major 
tranquilizers (average daily neuroleptic dose 
in chlorpromazine equivalents 150-750 mg); 
Age (mean, SD) Experimental = 31.5 (18-52), 
Control = 30 (22-60), "0" = 31.5 (22-54); 
Illness duration in years (range) 
Experimental = 6 weeks to 2.6 years, 
Control = 3 weeks to 10 years, "0" = 5 weeks 
to 6 years 
Not reported 
Hogarty, USA, 
2004, RCT, 12 & 24 
months  
Adults with 
schizophrenia or 
schizoaffective 
disorder from a 
medical centre, 
121; CACR = 67, 
Enriched supportive 
therapy (EST) group 
= 54 
Characteristics not separated by group. 
Diagnosis (% of total sample) Paranoid 
schizophrenia = 56, Schizoaffective disorder 
= 30, Other schizophrenia = 14 
Not reported 
Jones, UK, 2001, 
RCT, 12 weeks 
Adults with 
schizophrenia in 
community mental 
health services, 
112; Computer only 
= 56, Nurse + 
computer = 28, 
Nurse only = 28 
Characteristics not separated by group; 
Aged between 18 and 65 years; Male (%) 67 
Not reported 
Keefe, USA, 2012, 
RCT, 12 weeks 
Adults with 
schizophrenia at 
one of nine sites of 
the Schizophrenia 
Trials Network, 53; 
CACR = 27, control 
= 26 
Characteristics not separated by group; Age, 
mean (SD): 37 (10.27); Male /Female: 
39/14; White/ Black/ Other: 30/18/5 
CGI (mean, SD) 
Control = 3.62 
(0.75) Treatment = 
3.41 (0.84); PANSS 
(mean, SD) Control 
= 56.69 (15.35) 
Treatment = 55.70 
(13.75) 
Kuosmanen, 
Finland, 2009, RCT, 
follow-up not 
reported 
Adults with 
schizophrenia on 
nine acute wards in 
two psychiatric 
hospitals, 311; IT 
education group  = 
100, Conventional 
education group = 
106, TAU = 105 
Female (%) IT = 39, Conventional education 
= 39, Standard care = 45; Age (mean, SD) IT 
= 37.3 (12.4), Conventional education = 39.1 
(12.6), Standard care = 37.9 (12.8) 
 
PANSS total score 
(mean, SD) IT = 70.9 
(18.2) conventional 
= 70.1 (20.6) 
standard care 73.2 
(23.4) 
Kurtz, USA, 2007, 
RCT, 12 months  
Adults with 
schizophrenia or 
schizoaffective 
disorder attending 
The Institute of 
Living and a 
Male (%) CR = 60, CS = 74; Age (mean, SD) 
CR = 36.7 (12.2), CS = 32.9 (9.3); Duration of 
Illness in years (mean, SD) CR = 11.0 (10.4), 
CS = 9.8 (6.3); Treated with antipsychotic 
medicine (%) CR = 91, CS = 95 
 
Not reported 
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community centre, 
42; CACR = 23, 
control = 19 
 
Lee, Korea, 2013, 
RCT, 12 weeks 
Adults with 
schizophrenia 
referred to a 
psychiatric 
rehabilitation unit, 
60; CACR = 30, 
control = 30 
Male (n) CT = 16/14 UR = 17/13; Age (mean, 
SD) CT = 43.53 (4.87) UR = 43.46 (3.53); 
Duration of illness in years (mean, SD) CT = 
17.75 (4.14) UR = 17.53 (3.03); Medication 
in chlorpromazine mg daily equivalents 
(mean, SD) CT = 316.58 (182.15) UR = 
317.08 (182.23) 
PANSS (mean, SD) 
Positive symptoms 
CT = 15.21 (3.65) 
UR = UR 15.20 
(3.65); Negative 
symptoms CT = 
15.43 (4.24) UR = 
15.69 (4.69); 
General 
psychopathology CT 
= 33.29 (6.89) UR = 
33.22 (6.78) 
Madoff, USA, 1996, 
RCT, 1 week, 4 
weeks & 12 weeks 
after discharge 
Adult acute 
psychiatric 
inpatients, 42; 
Computer = 34, 
control = 21 
Male (n, %) Computer = 17 (50), Control = 8 
(38); Age (mean, SD) Computer = 35.6 (9.5), 
Control = 34.6 (9.6); White ethnic group (n, 
%) Computer = 22 (65), Control = 13 (65) 
Not reported 
Mak, Poland, 2013, 
RCT, 8 weeks 
Adults with 
paranoid 
schizophrenia, 81; 
CACR = 41, control 
= 40 
Male (n) CACR = 19, control = 18; Age 
(mean, SD) CACR = 34 (11.07), control = 39 
(12.99); Illness duration (mean, SD) CACR = 
9 (7.21), control = 11 (8.56); Olanzapine 
CACR = 18 Control = 16; Ziprasidone CACR = 
5 Control = 12; Perazine CACR = 7 control = 
9; Clozapinum CACR = 3 Control = 0; 
Quetiapinum CACR = 1 Control = 0; 
Amisulpridum CACR = 1 Control = 0; 
Risperidone CACR = 2 Control = 3; 
Zuclopenthixol CACR = 3 Control = 0 
PANSS Positive 
scale (mean, SD) 
CACR = 9.10 (2.25) 
control = 14.45 
(7.10); PANSS 
Negative scale 
CACR = 13.68 (5.99) 
control = 20.98 
(7.07); General 
psychopathology 
scale CACR = 24.59 
(7.14) control = 
33.73 (9.22) 
Montes, Spain, 
2010, RCT, 16 
weeks 
Adults with 
schizophrenia 
treated at 
community mental 
health centres, 928; 
Intervention = 456, 
Control = 472 
Male n (%) Intervention = 276 (65.1) Control 
= 288 (65.5); Age (mean, SD) Intervention = 
40.7 (11.8) Control = 39.5 (11.5); Duration 
of illness in years (mean, SD) Intervention = 
13.5 (9.7) Control = 12.7 (9.4); Treatment 
with atypical antipsychotics n (%) 
Intervention = 406 (96.0) Control = 425 
(96.4); Schizophrenia subtype n (%) 
Paranoid Intervention = 309 (72.9) Control = 
319 (72.7); Undifferentiated Intervention = 
52 (12.3) Control = 51 (11.6); Disorganized 
Intervention = 18 (4.3) Control = 24 (5.5); 
Residual Intervention = 45 (10.6) Control = 
45 (10.3) 
CGI-SCH SI score 
(mean, SD) Positive 
symptoms 
Intervention = 2.7 
(1.3) control = 2.7 
(1.3); Negative 
symptoms 
Intervention = 3.3 
(1.3) control = 3.2 
(1.3); Global 
symptoms 
Intervention = 3.3 
(1.2) control = 3.2 
(1.2) 
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Park, Korea, 2011, 
RCT, 5 weeks 
Adults inpatients 
with schizophrenia, 
91; Social skills 
training- virtual 
reality (SST-VR) = 
46, Social skills 
training-traditional 
role play (SST-TR) = 
45 
Female n (%) SST-VR = 17 (51.5), SST-TR = 13 
(41.9); Age (mean, SD) SST-VR = 28.1 (7.7), 
SST-TR = 31.2 (7.7); Duration of illness in 
years (mean, SD) SST-VR = 6.0 (5.7) SST-TR = 
5.9 (6.3); Medications n (%) Atypical 
antipsychotics SST-VR = 30 (90.9) SST-TR = 
29 (93.5); Typical antipsychotics SST-VR = 6 
(18.2) SST-TR = 5 16.5; Mood stabilizers SST-
VR = 1 (3.0) SST-TR = 1 (3.2); 
Antidepressants SST-VR = 1 (3.0) SST-TR = 3 
(9.7); Benzodiazepines SST-VR = 9 (27.3) 
SST-TR = 7 (22.6) 
 
PANSS (mean, SD) 
total SST-VR = 73.3 
(12.6) SST-TR = 71.4 
(12.7); Positive 
symptoms SST-VR = 
18.1 (5.3) SST-TR = 
17.0 (5.1); Negative 
symptoms SST-VR = 
18.9 (4.8) SST-TR = 
18.4 (4.7); General 
symptoms SST-VR = 
36.3 (8.6) SST-TR = 
36.0 (8.9) 
Priebe, centres in 
Spain, The 
Netherlands, UK, 
Sweden, Germany 
& Switzerland, 
2007, RCT, 12 
months 
Adults with 
schizophrenia or 
related psychotic 
disorder treated in 
community 
psychiatric services, 
507; DIALOG= 271, 
TAU = 236 
Age in years, mean (s.d.) TAU = 41.8 (11.6), 
DAILOG =  42.5 (11.3); Female, n (%) TAU = 
83 (35.2), DIALOG = 88 (32.5); Diagnosis n 
(%) undifferentiated schizophrenia TAU = 89 
(37.7) DIALOG = 91 (33.6), Paranoid 
schizophrenia TAU = 63 (26.7) DIALOG = 89 
(32.8), Catatonic schizophrenia TAU = 4 (1.7) 
DIALOG = 1 (0.4), Hebephrenic 
schizophrenia TAU = 10 (4.2) DIALOG = 7 
(2.6), Schizoaffective manic TAU = 7 (3.0) 
DIALOG = 19 (7.0), Schizoaffective 
depression (moderate) TAU = 9 (3.8) 
DIALOG = 9 (3.3); Schizoaffective depression 
(severe) TAU = 2 (0.8) DIALOG = 3 (1.1); 
Schizoaffective bipolar disorder 9 (3.8) 15 
(5.5); Delusional disorder TAU = 2 (0.8) 
DIALOG = 1 (0.4); Other non-organic 
psychotic disorders TAU = 41 (17.4) DIALOG 
= 36 (13.3); Length of illness, years, mean 
(s.d.) TAU = 15.2 (9.9) DIALOG = 16.6 (10.5) 
PANSS sub-scale 
scores:mean (s.d.) 
Positive TAU = 14.6 
(5.7) Intervention = 
15.0 (5.8); Negative 
TAU = 15.7 (6.0) 
Intervention = 17.2 
(6.9); General TAU 
= 31.8 (9.1) 
Intervention = 32.6 
(10.1) 
Proudfoot, 
Australia, 2012, 
RCT, 12 weeks & 6 
months 
Adults with bipolar 
disorder at the 
Black Dog Institute 
Mood Disorders 
Clinic, 419; Bipolar 
Education Program 
(BEP) = 139, BEP 
plus online support 
(BEP+IS) = 134, 
control = 134 
Male n (%) BEP = 46 (33.1%), BEP + IS = 36 
(26.9%), Control = 41 (30.6%); Age n (%) 18–
29 BEP = 43 (30.9%) BEP + IS = 38 (28.4%) 
Control = 36 (26.9%), 30–39 BEP = 49 
(35.3%) BEP + IS = 47 (35.1%) Control = 54 
(40.9%), 40–49 BEP = 28 (20.1%) BEP + IS = 
35 (26.1%) Control = 30 (22.4%), 50–59 BEP 
= 15 (10.8%) BEP + IS = 13 (9.7%) Control = 
10 (7.5%), 60+ BEP = 4 (2.9%) BEP + IS = 1 
(0.7%) Control = 4 (3%); Currently taking 
medication n (%) BEP = 114 (82.0%) BEP + IS 
= 115 (85.8%) Control = 114 (85.1%) 
Not reported 
Rass, USA, 2012, 
RCT, 5 weeks, 10 
weeks & 20 weeks 
Adults inpatients 
with schizophrenia 
or schizoaffective 
disorder, 48; CACR 
= 17, Active Control 
= 17, TAU = 10 
Male (n) CR = 10, Active control = 11, TAU = 
9; Age (mean, SD) CR = 37.2 (12.5), Active 
control = 45.4 (9.0), TAU = 43.9 (8.9); Illness 
duration (mean, SD) CR = 17.9 (11.6), Active 
control = 22.6 (12.1), TAU = 19.9 (9.3); 
Schizoaffective Disorder (n) CR = 9 Active 
PANSS Positive 
(mean, SD) CR = 
15.2 (5.6) Active 
control = 16.5 (6.2) 
TAU = 13.6 (3.8); 
PANSS Negative 
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control = 11 TAU = 2 (mean, SD) CR = 
12.4 (5.5) Active 
control = 13.2 (5.4) 
TAU = 15.0 (3.9); 
PANSS General 
(mean, SD) CR = 
27.3 (7.9) Active 
control = 30.6 (8.2) 
TAU = 26.0 (3.8) 
Sartory, Germany, 
2004, RCT, 3 weeks 
Adults inpatients 
with chronic 
schizophrenia, 42; 
CACR = 21, TAU = 
21 
Male (n) CR = 14, TAU = 14; Age (mean, SD) 
CR = 32.2 (8.5), TAU = 31.6 (8.9); Illness 
duration (mean years, SD) CR = 5.5 (4.8), 
TAU = 6.8 (5.5); Chlorpromazine equiv. (mg) 
CR = 550.92 (323.9) TAU = 584.8 (318.1) 
No reported 
Simon, USA, 2005, 
RCT, 12 months 
Adults with bipolar 
spectrum disorder 
at four group-
model behavioural 
health clinics, 441; 
Intervention = 212, 
TAU = 229 
Female n (%) Intervention = 144 (68) Usual 
Care = 157 (69); Age (mean, SD) 
Intervention = 44.1 (13.4), Usual Care = 44.3 
(12.9); Caucasion n (%) Intervention = 184 
(87), Usual Care = 206 (90); Type 1 bipolar 
disorder n (%) Intervention = 165 (78) Usual 
Care = 171 (75) 
Baseline mania PSR 
mean (SD) 
Intervention = 2.77 
(1.72) Usual care = 
2.78 (1.60); Current 
psychotic 
symptoms n (%) 
Intervention = 33 
(16) Usual care = 30 
(13) 
Simon, USA, 2006, 
RCT, 24 months 
Adults with bipolar 
spectrum disorder 
at four group-
model behavioural 
health clinics, 441; 
Intervention = 212, 
TAU = 229 
Female n (%) Intervention = 144 (68) Usual 
Care = 157 (69); Age (mean, SD) 
Intervention = 44.1 (13.4), Usual Care = 44.3 
(12.9); Caucasion n (%) Intervention = 184 
(87), Usual Care = 206 (90); Type 1 bipolar 
disorder n (%) Intervention = 165 (78) Usual 
Care = 171 (75) 
Baseline mania PSR 
mean (SD) 
Intervention = 2.77 
(1.72) Usual care = 
2.78 (1.60); Current 
psychotic 
symptoms n (%) 
Intervention = 33 
(16) Usual care = 30 
(13) 
Španiel, Czech 
Republic, 2012, 
RCT, 12 months 
Adults with 
schizophrenia or 
schizoaffective 
disorder at 36 
outpatient 
psychiatric centres, 
158; Active group = 
79, control = 79 
Female (%) Active = 41.3 Control = 46.5; Age 
(mean, SD) Active = 32.4 (9.8) Control = 33.7 
(10.4); Illness duration in months (mean, 
SD) Active = 101.4 (69.7) Control = 112.5 
(91.2); Diagnosis schizophrenia/ 
schizoaffective n/n Active = 52/23 Control = 
52/19 
CGI-S score (mean, 
SD) Active = 2.3 
(0.7) Control = 2.3 
(0.7) 
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The 31 articles reported 29 trials. A total of 17 trials focused on people with schizophrenia, 9 people 
with schizophrenia or schizoaffective disorder and/or psychotic disorder and 3 bipolar disorder. A 
range of telehealth devices were used with varying aims. Computers were used to improve cognitive 
functioning and disease-specific knowledge, websites aimed to improve psychosocial functioning, 
Todd, UK, 2014, 
RCT, 3 & 6 months 
Adults with bipolar 
disorder in the 
community, 122; 
'Living with Bipolar' 
Intervention (LWB) 
= 61, control = 61 
Male n (%) LWB = 16 (26%) WLC =18 (30%); 
Age in years (mean, SD) LWB = 42 (10.35) 
WLC = 45 (11.97); White British LWB = 55 
(90%) WLC = 54 (88%); Diagnosis: Bipolar I 
LWB = 47 (77%) WLC = 39 (64%), Bipolar II 
LWB = 11 (18%) WLC = 19 (31%), Rapid 
Cycling LWB = 3 (5%) WLC = 3 (5%) 
Internal States Scale 
(ISS) scores (mean, 
SD): ISS Perceived 
Conflict LWB = 
171.00 (102.92) 
WLC = 157.33 
(102.43), ISS 
Wellbeing LWB = 
100.44 (78.22) WLC 
= 106.86 (75.84), 
ISS Activation n 
LWB = 130.07 
(123.00) WLC = 
139.10 (127.33), ISS 
Depression LWB = 
86.32 (61.57) WLC = 
76.90 (52.35) 
Tsang, Hong Kong, 
2013, RCT, Not 
reported 
Adult inpatients 
with schizophrenia 
attending a 
vocational 
rehabilitation 
program, 95; VR = 
33, Therapist-
administered 
training (TA) = 32, 
control = 30 
Male (%) VR = 28 TA = 60 CG = 44; Age 
(mean, SD) VR = 39.60 (7.96) TA = 40.76 
(9.19) CG = 41.56 (9.94);  Illness duration in 
years (mean, SD) VR = 11.40 (7.08), TA = 
16.0 (8.73), CG = 16.64 (9.40); Medication 
(%) Typical VR = 28% TA = 32% CG = 36%, 
Atypical VR = 72% TA = 68% CG = 64% 
Not reported 
Vita, Italy, 2011, 
RCT, 24 weeks 
Adults with 
schizophrenia in 3 
rehabilitative 
centres, 84; 
Integrated 
Psychological 
Therapy (IPT-cog) =  
26, CACR = 30, Non-
cognitive 
rehabilitation 
(REHAB) = 28 
Female (n) IPT-cog = 5 CACR = 11 REHAB = 
10; Age in years (mean, SD) IPT-cog = 37.15 
(9.10), CACR = 36.87 (11.40), REHAB =  
43.00 (7.76); Duration of illness in years 
(mean, SD) IPT-cog = 14.94 (9.76) CACR = 
14.80 (9.78) REHAB = 17.93 (9.68); 
Chlorpromazine equivalents in mg (mean, 
SD) IPT-cog = 674.08 (417.97) CACR = 
600.17 (362.59) REHAB = 714.00 (445.32) 
CGI-S (mean, SD) 
IPT-cog = 5.0 (0.63) 
CACR = 4.67 (0.75) 
REHAB = 4.71 
(0.93); PANSS 
(mean, SD) Positive 
IPT-cog = 19.0 
(4.45) CACR = 18.97 
(5.91) REHAB = 
19.68 (6.67), 
Negative IPT-cog = 
28.73 (6.65) CACR = 
22.27 (7.95) REHAB 
= 21.18 (7.33) 
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hand-held devices were used to improve communication with medical staff, telephones were used 
to improve medication adherence and disease-specific symptoms, virtual reality aimed to improve 
social and work-related functioning, and electronic medication dispensers aimed to improve 
adherence. The specific outcome measures included, medication adherence (4 studies), social 
functioning (including work behaviour) (5 studies), healthcare utilisation (4 studies), neurocognitive 
functioning (16 studies), knowledge about medication or SMI (2 studies), self-esteem (3 studies), 
self-efficacy (1 study), quality of life (4 studies), mood (4 studies), insight into condition (1 study), 
perceptions of deprivation of liberty (1 study), satisfaction with life or treatment (5 studies), and 
illness perceptions (1 study). 
The 29 included trials recruited a total of 4,338 participants. Sample sizes ranged from 29 to 507. 
Details about each intervention can be seen in Table 2. 
Table 2. Descriptions of the interventions included in the review 
First author, country of 
origin, year, design, 
length of follow-up 
Technology  Description of intervention and comparator 
Beebe, USA, 2008, RCT, 
12 weeks 
Telephones  Participants received all usual care plus weekly 
telephone calls from a nurse over a period of 3 
months. TAU consisted of the usual medications, 
physician visits, follow-up appointments, and care 
available at the community centre.  
Bellucci, USA, 2002, 
RCT, 8 weeks 
Computers Participants received computer-based cognitive 
training from a psychology intern. Training sessions 
were administered in a private office in two half-
hour sessions for 8 weeks. The waiting-list control 
group took part in standard therapeutic activities in 
the day treatment programme and received 
computer training at the end of the study 
Benedict, USA, 1994, 
RCT, follow-up not 
reported 
Computers Participants received a mean of 14.4 (SD 1.09) 50-
minute sessions of guided practice with six 
computer-based attention tasks administered by 
trained undergraduate research assistants. Three to 
five training sessions were scheduled per week. TAU 
participants received the same multidisciplinary, 
day-treatment program as experimental 
participants.  
Burda, USA, 1994, RCT, 
8 weeks 
Computers Participants received 24 half-hour sessions (or 12 h) 
of CACR training over 8 weeks. The TAU group did 
not use computers and participated in regular 
therapeutic activities on the ward.  
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Cavallaro, Italy, 2009, 
RCT, 12 weeks 
Computers Participants received neurocognitive exercises for 3 
half-days a week for approx. 15 months. Sets of 
exercises were individually created for each 
participant on the basis of the quality of baseline 
neuropsychological assessment. The SRT+CRT 
condition consisted of three 1-h sessions a week for 
a period of 12 weeks, giving a total of 36 h. The 
control condition consisted of 1 h a week of 
computer-aided non-domain-specific activity and 2 
extra h a week of standard rehabilitation 
programme (SRT). 
Chan, Hong Kong, 2010, 
RCT, 10 weeks 
Virtual reality Participants received a series of simulated tasks 
within a VR environment through video contact 
twice a week. Ten sessions, each 15 min long, with 
increasing level of difficulty, was provided by an 
occupational therapist and consisted of two 
activities. Participants in the control group received 
TAU and the VR program 3 months later. 
D’Amato, France, 2011, 
RCT, 12 weeks 
Computers The CACR group received, in addition to standard 
treatment, 14 individual 2 hour sessions of training 
in selecting, executing, and monitoring cognitive 
operations delivered over a 7-week period by a 
psychologist.  
Dickinson, USA, 2010, 
RCT, 12 weeks 
Computers 
 
 
 
The CACR group received 36 sessions of cognitive 
remediation. Time in individual sessions included 
practice of cognitive exercises (roughly two-thirds of 
each session) alternated with trainer prompts, 
queries and feedback, and strategy review. Control 
group participants received the same amount of 
time on computers with the same trainers as the 
treatment group, but received gaming activities with 
low cognitive demand. 
Frangou, UK, 2005, RCT, 
8 weeks 
Electronic 
medication 
dispenser 
@HOME participants used a medication dispenser 
with a Medication Event Monitoring System 
(MEMSIV®). The bottle cap recorded when the 
bottle was opened and data were transmitted to the 
research and clinical teams via the @HOME 
platform. Alerts were issued if participants took less 
than 50% of their prescribed medication over 1 
week.  The Pill Counting group consisted of 
pharmacists counting the numbers of tablets 
returned at the hospital visit. TAU received standard 
care. 
Hansson, Multicentre 
(Spain, The 
Netherlands, UK, 
Sweden, Germany & 
Switzerland), 2008, 
RCT, 12 months 
Computers Key workers in the intervention group discussed 
issues with their participants using a computer-
mediated procedure every 2 months. TAU continued 
with standard treatment delivered by their key 
worker. 
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Hermanutz, Germany, 
1991, RCT, 4 weeks 
Computers Participants undertook computer exercises in 
attention 15 times during 3-4 weeks. The control 
group were instructed by a therapist in small groups 
to read newspaper articles and answer questions 
about, and reproduce, their content. The "0" group 
did not receive any kind of psychological training 
Hogarty, USA, 2004, 
RCT, 12 & 24 months  
Computers CACR consisted of combined 75 hours of progressive 
computer-assisted training in neurocognition and 
1.5 hours per week of social cognitive group 
exercises (approx. 56 sessions). Small groups of 6 
participants met 4 to 6 months after starting 
computer-assisted training. Participants were 
treated by 3 experienced psychologists. The therapy 
group received individual education delivered by 
two psychiatric nurses.  
Jones, UK, 2001, RCT, 
12 weeks 
Computers The computer only group were shown general 
information, personal information from their 
medical records and questionnaires. In community 
psychiatric nurse only, hour-long sessions covered 
the same content. The combination group received 
the community psychiatric nurse sessions, plus 24 
sessions on the computer and a final session with 
the nurse. All groups received 5 sessions in total. 
Keefe, USA, 2012, RCT, 
12 weeks 
Computers The CACR group received the computerized Posit 
Science Brain Fitness auditory training program for 
3–5 one-hour sessions weekly for 40 sessions or 12 
weeks, whichever came first. Participants also 
attended structured ‘bridging groups’ every week. 
The control group played computer games for the 
same number of hours, received the same amount 
of contact with personnel, and attended Healthy 
Lifestyle Groups. 
Kuosmanen, Finland, 
2009, RCT, follow-up 
not reported 
Computers The IT education group received needs-based 
computerised education from a nurse consisting of 5 
40-minute sessions delivered over one month. The 
conventional education group received 5 30-minute 
nurse-delivered education sessions with oral and 
written material in addition to standard care and 
were given leaflets. TAU received standard acute 
psychiatric care. 
Kurtz, USA, 2007, RCT, 
12 months  
Computers The CACR group received a 12-month, standardized 
course of cognitive remediation. The CS group 
received a 12-month course of tutorials in general 
computer literacy using Microsoft Office. 
Participants in both groups trained on computers 
side by side in rooms of 3–4 computers supervised 
and coached by both pre-doctoral, and doctoral level 
clinicians who offered positive reinforcement for 
progress on the respective training sequences.  
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Lee, Korea, 2013, RCT, 
12 weeks 
Computers The Cog-trainer program included 20 one-hour 
sessions of neurocognitive exercises delivered by a 
therapist up to two times a week over 3 months. The 
therapist provided support for tasks the participant 
could not accomplish and ceased assistance in those 
areas where competence was achieved. 
Madoff, USA, 1996, 
RCT, 1 week, 4 weeks & 
12 weeks after 
discharge 
Computers All participants completed assessments of familiarity 
with medication, followed by 4 sessions of a 
computer-based interactive educational program to 
improve medication knowledge. The control group 
received a nurse tutorial covering the same material.  
Mak, Poland, 2013, 
RCT, 8 weeks 
Computers The experimental group received 16 sessions (two 
per week) of CACR training. Sessions lasted about 40 
minutes, 20 minutes for each procedure out of 
attention/ concentration and topological memory. 
The control group were not treated with RehaCom. 
Montes, Spain, 2010, 
RCT, 16 weeks 
Telephones The IG received a standardized telephone call from a 
nurse at weeks 4, 8, and 12 consisting of a brief 
semi-structured assessment of treatment adherence 
and the Drug Attitude Inventory (DAI-10). The 
treating psychiatrist received a structured report of 
each contact and, if non-adherent, the participant 
was scheduled to visit the psychiatrist within the 
next 7 days. The control group received usual care (a 
visit from the psychiatrist after 4 months, without 
telephone calls). 
Park, Korea, 2011, RCT, 
5 weeks 
Virtual reality Both groups received 3 training sessions in 
conversation skills, assertiveness skills and 
emotional expression skills administered semi-
weekly for 10 sessions. Each session included a 
therapist modeling followed by role-playing and 
then positive and corrective feedback. Each session 
included different scenes per participant. The VR 
group received a personal computer providing the 
virtual environment, a head mounted display, and a 
position tracker for following the head direction in 
real time.  
Priebe, centres in Spain, 
The Netherlands, UK, 
Sweden, Germany & 
Switzerland, 2007, RCT, 
12 months 
Computers DIALOG consisted of a computer-mediated 
procedure for clinicians to discuss 11 domains with 
their participants. Clinicians were instructed on how 
ratings should be used to facilitate a dialogue with 
participants, identifying changes since the last rating, 
explicit dissatisfaction with life domains or 
treatment aspects, or the participant wanted 
additional or different support. The control group 
continued with TAU.  
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Proudfoot, Australia, 
2012, RCT, 12 weeks & 
6 months 
Computers The BEP group received ‘MoodSwings’, an online 
self-help audio–visual program based on CBT 
modules. Participants completed 6 modules, taking 
30–40 min to complete, over 3 months with a small 
group moderated discussion and 3 booster modules 
at 3, 6 and 12 months. The BEP+IS group received 
the online psychoeducation program supplemented 
by coaching and support from peers with bipolar 
disorder who had managed their condition for at 
least 2 years via email. The control group received 
simple facts about bipolar disorder delivered as brief 
online text. 
Rass, USA, 2012, RCT, 5 
weeks, 10 weeks & 20 
weeks 
Computers The CACR group completed a cognitive training 
programme for 2 hours 2 days per week for 10 
weeks. The active control group watched films, 
cartoons, or television shows using the same 
schedule. TAU participants came in only for 
assessments.  
Sartory, Germany, 
2004, RCT, 3 weeks 
Computers CACR involved a computerized training program 
consisting 30 computer tasks designed to train 
attention and concentration. The training, labelled 
"computer game sessions", was delivered 45 mins 
per day for 15 days in small groups of up to 6 with an 
attendant present at all times. TAU received 
standard care and later received CACR 
Simon, USA, 2005, RCT, 
12 months 
Telephones Participants received structured monthly telephone 
medication monitoring for 24 months and a 
structured group psychoeducational program 
provided by a nurse care manager. Telephone 
monitoring and care management were supported 
by a web-based computer application integrating 
contact tracking, structured assessment, 
pharmacotherapy recommendations, and feedback 
reports to care providers. The group 
psychoeducational program included 5 weekly group 
sessions (Phase 1) followed by twice-monthly 
sessions (Phase 2). TAU received no additional 
services.  
Simon, USA, 2006, RCT, 
24 months 
Telephones Participants received a collaborative treatment plan 
with the nurse care manager and monthly telephone 
call for 24 months to review SMI symptoms, 
medication use, and adverse effects. Nurse care 
managers sent structured feedback to mental health 
providers. Participants attended a group 
psychoeducational program including five weekly 
group sessions (Phase 1) followed by twice-monthly 
sessions for a total of up to 48 sessions (Phase 2). 
TAU received no additional services. 
Španiel, Czech Republic, 
2012, RCT, 12 months 
Telephones All participants received the Information 
Technology-Aided Program of Relapse Prevention in 
Schizophrenia (lTAREPS) consisting of automatic SMS 
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Risk of bias 
Results for the risk of bias assessment can be found in Multimedia Appendix 1: Risk of bias 
assessment. Of note, only five studies were rated as high quality. One study demonstrated a 
particularly high and at times unclear risk of bias, for the majority of sources of bias [49]. Several 
studies did not provide enough detail to be able to make a clear judgement that they had not 
introduced bias into their findings. 
requests once a week to participants' and their 
families' mobile phones to complete questionnaires 
about symptoms for 12 months. Participants sent 
their scores via SMS and if a total score exceeded a 
threshold, an automatically generated e-mail was 
sent to the treating psychiatrist. In the active group, 
ITAREPS reported the occurrence of prodromes to 
the investigators via emails. Control group did not 
receive the e-mail service 
Todd, UK, 2014, RCT, 3 
& 6 months 
Computers Participants received an online interactive self-
management intervention based on CBT principles 
and psycho-education. Ten interactive modules were 
available; participants used it when they felt it 
appropriate. Generic email prompts were sent to 
participants every fortnight. Participants were also 
encouraged to make use of peer support. The WLC 
group received TAU. 
Tsang, Hong Kong, 
2013, RCT, Not 
reported 
Virtual reality All participants attended at least 3 hours of 
prevocational skills training in the OT Department in 
hospital in every working day during hospitalization. 
VR participants also attended vocational skills 
training in a virtual boutique scenario (VRVTS). In TA, 
participants attended prevocational skills training 
and therapist-administered vocational skills training 
program in a boutique. The training content of VR 
and TA were the same and all participants were 
required to attend 10 30-min sessions of training 
over 5 weeks.  
Vita, Italy, 2011, RCT, 
24 weeks 
Computers Participants received a group-based structured CBT 
program with neurocognitive and social cognitive 
remediation integrated into psychosocial 
rehabilitation over 5 modules. CACR consisted of the 
Cogpack programme. The comparison group 
participated in group psychosocial interventions, 
consisting of different types of activities (e.g. art 
therapy or physical training), administered for the 
same amount of time as the intervention.  
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Intervention effectiveness 
Results for each of the 31 studies can be found in Multimedia Appendix 2: Results of included 
studies. A description of the findings is presented in the following sections.  
Cognitive outcomes 
Twenty of the 31 articles reported the impact of telehealth for SMI on cognitive outcomes. 
Neurocognitive functioning was measured in 18 studies and encompassed memory, attention, 
executive functioning, and visual perception. Fifteen of these studies measured the impact of 
computer-assisted cognitive rehabilitation (CACR) on neurocognitive functioning [18-32], of which 11 
found statistically significant improvements [20-24; 26; 28 -31; 33]. Two of the 18 studies evaluated 
the use of VR, for cognitive rehabilitation [33] and vocational rehabilitation [34] for adults with 
schizophrenia. VR was found to have a significant effect on cognitive functioning in both studies 
[33;34]. One study [35] evaluated the use of offline personalised computer-based health education, 
compared to nurse-delivered health education, and a combination of both interventions but found 
no significant differences from baseline to follow-up in any of the trial arms on measures of 
neurocognitive functioning or knowledge about schizophrenia [35; 36].  
To summarise the findings for cognitive outcomes, 11 out of 15 studies found computer-assisted 
cognitive remediation (CACR) to be beneficial for cognitive outcomes, and virtual reality-based 
cognitive and vocational training was found to be effective for cognitive function, while computer-
based patient education was found to have no benefit for cognitive outcomes over nurse-delivered 
education.  
Psychosocial outcomes 
Twenty-one of the 31 articles reported the impact of telehealth on psychosocial outcomes. These 
included positive and negative symptoms [28; 21; 22; 24; 27; 30; 36; 37; 38], social adaptation 
including social adjustment and cognition [21; 24; 27; 28; 31; 39- 41], quality of life [20; 21; 39; 40; 
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36; 38; 42], mood [31; 39; 36; 43; 44], satisfaction with care [42], self-esteem [18; 24; 39], self-
efficacy [34], illness perceptions [39], insight [35], and perceptions of deprivation of liberty [45].  
Positive and negative symptoms 
Six studies evaluated the effectiveness of CACR on schizophrenia symptoms [18; 21; 22; 24; 27; 30], 
of which four did not find any effect but two [18] [27] found a beneficial effect on negative 
symptoms [18;27]. One study also measured positive symptoms and global symptoms, finding a 
beneficial effect on positive symptoms [27] but not global symptoms [27].  
Telephone-based nurse support [36] reduced positive schizophrenia symptoms when compared to a 
control group, but no differences were observed for negative or global schizophrenia symptoms 
[36]. Telemonitoring [37] had a beneficial effect on positive and negative schizophrenia symptoms 
over standard care, although a non-technology “pill counting” group also led to improved symptoms.  
Computer mediated structured consultations [38] did not have an impact on symptoms.  
Social adaptation 
The included trials measured several different aspects of social adaptation. These included social 
cognition, social adjustment, social professional and family functioning.  
Eight of the 31 studies evaluated the impact of telehealth on social adaptation, encompassing social 
adjustment and social cognitions, of which three reported a benefit. Of five trials of CACR, two 
reported a beneficial effect, on the social and living conditions subscales of the Health of the Nation 
Outcome Scale (HoNOS; 46) [27], social adjustment (defined as role performance) and social 
cognition (defined as awareness of relationships), which were measured using a combination of 
existing outcome measures [28]. However, others found no effect of CACR on social autonomy [21], 
social professional and family functioning [31] or social cognition as measured by the Matrics 
Consensus Cognitive Battery (MCCB; 47) [24].  
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An online self-management intervention [40] improved social functioning but an online CBT-based 
intervention (alone or with peer support) [39] did not affect perceptions of stigmatisation. Using 
virtual reality to deliver social skills training [41] did not differ from social skills training with role-play 
on social problem-solving, social adjustment or stigma. 
Quality of life 
Seven articles reported the impact of telehealth for SMI on quality of life. Three studies found a 
significant benefit of telehealth for SMI. CACR had a significant effect on overall quality of life and a 
self-directedness subscale in one study [20], but not in another [21]. Computer mediated structured 
consultations (“DIALOG”) improved quality of life at a 12 month follow-up [38]. Service users with a 
shorter duration of illness and a better ‘perceived helping alliance’ with key workers prior to 
receiving DIALOG improved more in subjective quality of life than standard care [42]. Hansson et al 
[42] also found that people with more severe negative schizophrenia symptoms prior to the 
intervention experienced a greater improvement in quality of life after receiving DIALOG. Online 
self-management [40] had a significant effect on both physical and psychological quality of life but 
nurse-based telephone support [36] was not effective.   
Two studies measured satisfaction with life. There were no significant differences between 
‘Moodswings’, ‘Moodswings’ plus online peer support, and a standard care control group, on 
satisfaction with life [39]. Similarly, there was no difference between an IT education group and 
standard care on satisfaction with life [45].   
Mood 
A nurse-delivered monthly telephone monitoring intervention [43;44] reduced depressive symptoms 
for bipolar disorder after 12 months, but this effect was not maintained at the two year follow-up. 
Furthermore, a significant reduction in mania was found at the two-year follow-up, but not at the 
initial 12-month assessment. No benefit was found for CACR [31], an online CBT-based intervention 
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[39], or a telephone-based nurse support intervention [36] over a no treatment control. Noteworthy 
is the control condition in Proudfoot et al’s [39] study, which involved information about bipolar 
disorder being emailed to participants weekly.  
Satisfaction with health care 
One trial measured the effectiveness of telehealth on satisfaction with care. Computer-mediated 
consultations improved treatment satisfaction [42]. 
Self-esteem 
Three studies measured the impact of telehealth for SMI on self-esteem. Self-esteem was not 
improved by CACR [18;24], or by an online CBT-based intervention [39].  
Self-efficacy 
The one study that measured self-efficacy, found no differences between VR vocational training, 
therapist-administered vocational training, and a non-training control group in terms of self-efficacy 
for performing work-related tasks [34].   
None of the computer-based education trials found a significant impact on insight into schizophrenia 
[35], or perceived deprivation of liberty among adults with schizophrenia [45].  
To summarise the findings for psychosocial outcomes, CACR was found to have no effect on 
schizophrenia symptoms in the majority of studies that measured this outcome, and had no effect 
on mood over standard care. Two out of three studies that measured the impact of CACR on 
psychosocial adjustment found an improvement. Telephone support was found to reduce the 
severity of positive symptoms and depressive symptoms in schizophrenia and remote telemonitoring 
was found to improve global schizophrenia symptoms over pill-counting alone. Computer-mediated 
structured consultations and online self-management for bipolar disorder were both found to lead 
to improvements in quality of life. While online patient education improved social functioning, it had 
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no effect on mood. VR had no benefits in improving nonverbal social skills over traditional face to 
face training.  
Behavioural outcomes 
Ten of the 31 studies measured the effectiveness of telehealth interventions on behavioural 
outcomes. Outcomes included adherence to treatment [36; 37; 48; 49], healthcare utilisation, 
including number of inpatient days and amount of antipsychotic medication taken [37; 43; 50; 40], 
work habits [22; 34], and conversational skills, including non-verbal skills [41] 
Adherence to treatment 
Of the four studies that measured adherence to treatment, significant improvements were found 
with nurse-based telephone support [48; 36] and telemonitoring [37], but not for computer-based 
medication education [49].   
Healthcare utilisation 
Of the four studies that evaluated the use of telehealth on healthcare utilisation, all found a 
significant positive effect. Remote medication monitoring [37] led to fewer medical and emergency 
visits than pill counting alone and standard care.  Telemonitoring of symptoms [50] led to 
significantly fewer inpatient days when compared to a control group who received standard care. 
Simon et al [43] found better adherence to atypical antipsychotic use and increased attendance for 
medication management visits in service users who received nurse-based telephone support.  Todd 
et al [40] reported that medication and service use reduced on average in the self-management 
website group and increased on average for the standard group, although statistical analysis of the 
difference is not reported. 
Work habits 
Of the two studies that measured work habits, which involved direct observation of work behaviour 
and an interview with the work supervisor, both found the telehealth intervention to be effective. 
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CACR [22] had a significant effect on work habits and VR [34] was as effective as therapist-delivered 
vocational training for work-related tasks, with a significant improvement seen in both groups.  
Conversational skills 
Park et al [41] found that enabling service users to practice their social skills using VR after receiving 
social skills training, had a significant effect on conversational skills and assertiveness in comparison 
to a face-to-face role playing group (without VR), although the role playing group showed greater 
improvement in nonverbal skills.  
To summarise the findings for behavioural outcomes, telephone support and remote telemonitoring 
consistently led to improvements in medication adherence and reduced inpatient days, while 
computer-based education had no effect. Telemonitoring and online CBT-based self-management 
both led to reduced emergency healthcare visits. CACR and VR were both effective for improving 
work behaviour and VR improved assertiveness in social situations over traditional face to face 
training.  
 Acceptability  
Of note, only one of the included studies formally measured whether participants found the 
intervention they received acceptable. Frangou et al [37] measured acceptability, ease of use within 
routine care, and perceived effectiveness qualitatively from the perspective of service users and 
their healthcare professionals. There was unanimous agreement among service users that the 
telemonitoring intervention helped them to manage their own condition, was easy to use and easy 
to incorporate into daily life, and caregivers shared these views [37]. While Park et al [41] did not 
report measuring ‘acceptability’, they did record ‘interest in participation’ using a two-item 
questionnaire, which evaluated participants’ interest in the session they received and their 
expectations for the next session. The VR group scored higher on interest in participation than the 
traditional social skills training group [41], suggesting a preference for technology. Jones et al [35] 
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similarly did not refer to ‘acceptability’, but assessed participants’ opinions about the computer-
based education intervention combined with nurse-based education, versus computer-based or 
nurse-based education alone. Significantly more service users in the nurse-based education group 
perceived the information they received as definitely relevant to them compared to the computer-
delivered education group and the combination group, despite the nurse-delivered intervention 
providing the same content as the computer system [35].  
One indicator of acceptability may be significant drop-out rates from the intervention group. Most of 
the included studies did not present a substantial drop-out rate, although not all studies adequately 
reported reasons for drop-out. Of the studies reporting a substantial drop-out rate, Proudfoot et al 
[39] reported a higher dropout from  the website condition (30%), compared to the website plus 
peer support condition (19%). Jones et al [35] reported substantial drop-outs from the computer-
delivered education (41%) and nurse-delivered education conditions (46%), when compared to the 
combined condition (29%). Reasons for drop-out from the computer education group included 
refusal to continue taking part, the intervention being unsafe, and physical problems limiting the 
ability to continue with the intervention [35]. Rass et al [25] also reported a higher drop-out from a 
CACR group (19%) than either control condition (0%), including three participants who stopped 
attending the intervention and two who did not complete final follow-up assessments. In a 
longitudinal study assessing telephone monitoring plus a structured group psychoeducational 
programme, while the authors reported a high level of contact in the telephone element of the 
intervention (85% of participants completed 12 or more telephone contacts), group participation 
dropped substantially to 51% after 12 months [44], suggesting a group-based education intervention 
may be less acceptable than telephone monitoring in adults with bipolar disorder.
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Discussion 
Principal results 
The aims of this review were 1. To identify which, and how, telehealth interventions have been 
trialled for people with SMI and 2. To synthesise the evidence in relation to the effectiveness or 
efficacy of these interventions.  
This review identified 31 articles describing 29 trials, including a total of 4,338 participants with 
schizophrenia, schizoaffective disorder, psychotic disorder and bipolar disorder. The studies in the 
included articles evaluated the use of computers for cognitive rehabilitation, patient education, 
consultations with key workers and interactive online CBT-based self-management interventions; 
the use of VR to simulate work and social situations and to deliver cognitive training; the use of 
telephones to prompt medications use and to report SMI symptoms to healthcare teams; and the 
use of remote sensors to monitor medication use.  
This review found evidence for using some types of technology to support the management of SMI, 
whilst finding that not all technology is effective, depending on the outcome of interest. 
Interventions containing telephone support from the medical team, including phone calls and SMS 
prompts about medication, were consistently found to be effective for improving medication 
adherence, whilst also reducing severity of mania symptoms and reducing inpatient days. CACR was 
found to be effective for improving cognitive outcomes in schizophrenia in most, but not all, studies. 
An online CBT-based self-management intervention for bipolar disorder was effective at improving 
quality of life and social functioning. The use of VR was found to be effective for improving work-
related behaviour, conversational skills, assertiveness and cognitive functioning, although face to 
face social skills training was found to be more effective for improving nonverbal social skills than VR 
delivered training. Computers appeared not to have a superior benefit for delivering patient 
education over traditional nurse-delivered education, and in fact participants preferred the nurse-
delivered method. This finding is perhaps reflective of the nature of interactions with healthcare 
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staff, which can provide a personal and individualised approach to supporting people with SMI, for 
example by offering opportunities like discussing diagnoses, and modelling nonverbal social cues. 
Hand-held devices to support healthcare consultations were found to be effective for improving 
quality of life and satisfaction with care, but not for improving positive or negative schizophrenia 
symptoms. Telemonitoring, which was found to be effective for improving medication adherence 
and also led to fewer medical and emergency visits, including inpatient days, whilst simultaneously 
improving schizophrenia symptoms.  
Notably, five studies demonstrated a low risk of bias for six out of the seven sources of bias listed in 
the Cochrane risk of bias tool [42; 27; 38; 43; 40], and six studies demonstrated a low risk of bias for 
five out of the seven sources [48; 22; 36; 39; 44; 50]. One study demonstrated a particularly high and 
at times unclear risk of bias, for the majority of sources of bias [49]. Several studies did not provide 
enough detail to be able to make a clear judgement that they had not introduced bias into their 
findings, particularly in reference to whether participants were assigned to groups using an 
adequate randomisation method and whether allocation had been truly concealed. The findings of 
this review should therefore be viewed in light of the potential bias introduced into the findings of 
some of the studies included.  
It is also worth noting the variety of comparison groups employed within the studies included in this 
review. In the majority of articles (n= 17), the authors reported that the comparison group received 
standard care, or treatment as usual. This may have differed between trials. For example in the 
context of inpatient care, this included medication and attendance at routine therapy groups [32] 
but in the context of community care, this might have included medication, physician visits and 
support available community centres [e.g. 48]. However for nine of the studies, the control group 
received a comparative intervention, consisting of healthcare professional-delivered education 
about their condition [28; 49] text-delivered education [39], therapist-delivered skills training or 
psychosocial interventions [34; 41; 27], or computer-delivered activity, such as computer games or 
education about their condition [20; 24; 35].  
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Comparison with prior work 
This review supports the findings of previous reviews evaluating cognitive training in schizophrenia 
[52; 53], although evidence suggests that cognitive training is effective regardless of whether it is 
delivered via computer technologies or non-computerised psychological interventions [52]. 
Substantial variations in intensities and duration of the interventions that used software to support 
neurocognitive training may have impacted on the results of these studies. If training was 
particularly intensive, for example half a day or delivered over several months, it is possible this 
might have overburdened participants with SMI, leading to a lack of significant findings or reduced 
participants’ attention abilities. A recent meta-analysis suggests that as little as 5 to 15 hours of 
cognitive remediation could be sufficient for improving cognitive outcomes in schizophrenia [53], 
suggesting that more intensive cognitive training may not be necessary and that future interventions 
should be designed with this in mind.   
CACR was most commonly assessed offline using PCs and CD-ROM software, with little change in the 
software used over time. With the rise in more sophisticated technologies, including VR, which in 
this review was found to improve social and neurocognitive outcomes in SMI, perhaps we can expect 
to see VR interventions delivered more widely to support SMI outcomes in the coming years. VR has 
the potential to provide usable and safe, ecologically valid assistance in the management of SMI, as 
already found in general healthcare [54]. In particular, our findings support a recent systematic 
review of VR for SMI and was found to be more interesting training than control conditions [55].  
We identified surprisingly few studies that had evaluated online interventions to support individuals 
with SMI. Educational websites were not found to be effective for improving knowledge about 
medication, adherence, self-esteem, insight into SMI or deprivation of liberty over traditional nurse-
delivered education. However, when websites provided more interactive elements than traditional 
education, such as peer support or CBT-based self-management techniques, improvements in 
quality of life, mood, and social adaptation were seen. Further research on the psychosocial benefits 
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of web-based interventions for people with SMI is suggested, particularly given the small number of 
studies to date and the growing evidence for such interventions in common mental health disorders, 
including anxiety and depression [56; 57]. Web-based interventions will however need to take the 
specific needs of people with SMI into account to improve accessibility. For example, service users 
often report that common website design guidelines produce websites that are confusing for them 
to use, particularly in the presence of cognitive deficits [58]. 
The finding that telephones were effective for promoting adherence to medication use and 
attendance at healthcare appointments was consistent with a recent systematic review [59] of 
mobile phone-based technologies for supporting general healthcare, and another review for the use 
of remote technology in SMI [59].Further evidence suggests that the use of telephones has a 
beneficial impact on adherence over interventions that do not use technology, for example 
psychoeducation, for patients who are non-adherent due to forgetfulness [60].  While telephone-
based interventions may not consistently improve clinical factors associated with SMI, the findings of 
the studies included in this review give early promise to the use of telephones in supporting adults 
with SMI to manage their medication. With advances in the function of telephones, including 
smartphone apps, this provides further opportunities for supporting people with SMI in the future. 
One might have expected more interventions, however, as Bakker et al [61] recently emphasised,  
mental health apps have not to date utilized the designs made available by physical health and social 
networking apps, nor have the hundreds of apps available been tested using formal experimental 
methods.  
The present review also found that the use of telephones improved patients’ attitudes towards using 
their treatment, as well as their quality of life. Leach and Christensen [62] suggest telephones are 
acceptable and cost-effective uses of technology to support healthcare due to their accessibility and 
convenience. A large scale survey of users of mental health services in the USA in 2013, found that 
72% reported owning a mobile device, and both users and non-users expressed an interest in future 
33 
 
services being offered through mobile devices [63], suggesting that accessing a mobile device may 
not pose a barrier to people with SMI.  
The positive findings for the use of telemonitoring to improve global schizophrenia symptoms, 
medication adherence and medical and emergency visits, are consistent with reviews that have 
found positive effects of telemonitoring for managing chronic health conditions, including heart 
failure [64] and respiratory conditions [65]. Furthermore, a recent review of the use of remote 
technology for SMI found this to be a feasible and acceptable method of healthcare delivery [66]. 
These are positive initial results for a form of telehealth that was found to be acceptable from both 
the service user and healthcare perspective and future research evaluating the use of telemonitoring 
for SMI could have implications for the delivery of future services for people with SMI.  
The finding that computer-mediated consultations led to improvements in quality of life and 
reduced unmet need in service users with SMI is promising for a novel use of technology, where 
there is currently a limited evidence base. One recent qualitative study reports that healthcare 
professionals perceive tablet computers to fill a need between smartphones and desktop computers 
and have some value in supporting consultations with patients [67]. Tablet computers offered 
support in structuring consultations, ensuring patients’ priorities were discussed [38] thus patients 
might feel their needs have been better dealt with.  
Few studies evaluated the use of remote medication telemonitoring, computer-mediated 
consultations, or online self-management resources, suggesting these are novel technologies for 
managing SMI, although all were found to be effective for improving psychosocial and behavioural 
outcomes. We were surprised to find the limited use of these more advanced technologies in an SMI 
context, given the rise in their use to support broader healthcare in recent years. For example, 
online self-management programmes for diabetes [51]. We suggest that future research should seek 
to establish the full potential benefits of these novel uses of telehealth for improving the 
management of SMI. 
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Of note is the varied quality of the studies included in the review, with only five studies rated as high 
quality. This suggesting high levels of bias were potentially introduced into the results of these 
studies. Of particular note is the small sample size of the majority of articles in this review, with 19 
out of the total 31 studies having samples of fewer than 100 participants. Furthermore the type of 
comparison or control group employed might have had an influence on the effect size of the 
intervention evaluated and noteworthy is the variety of comparison groups included in this review. 
The generalisability of the findings from many of these studies is therefore limited.  
Limitations 
To our knowledge this is the first systematic review of RCTs across a range of telehealth technology 
interventions delivered to people with SMI. The studies included in this review measured a plethora 
of outcomes using heterogeneous measures and a range of interventions, making meta-analysis of 
the results impossible. In addition, we excluded articles that had not been published in English. It is 
possible therefore that we excluded relevant foreign language articles from this review.  One author 
performed the data extraction process and while this was not verified by a second author, all 
authors were involved in the screening process and two authors independently completed the risk of 
bias assessment, thus several stages of the review process were validated by more than one author.  
Noteworthy is the lack of studies that formally evaluated the acceptability of telehealth 
interventions. Of those that did measure the opinions of their participants, telehealth was found to 
be acceptable particularly in comparison to more traditional face-to-face methods of the delivery.  
However, this may depend on whether a face-to-face element to the intervention is also offered, as 
it has been suggested that this may be preferable over unguided interventions [68]. If telehealth is 
to be developed to support the care of people with SMI, it is important that acceptability of the 
interventions is considered as part of the evaluation and formally measured. From a health 
commissioning perspective, it is also possible that telehealth delivery costs are higher than usual 
care [1]. Cost-effectiveness was not formally evaluated by the studies included in this review so it is 
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unclear if this is also the case with interventions in SMI. Future studies should evaluate the costs of 
using technology to support the management of SMI.   
Conclusions 
This systematic review has identified a range of ways in which telehealth has been used support the 
management of SMI and its symptoms. The studies found some strengths of cognitive remediation 
for schizophrenia, whether delivered by PC and CD-ROM or virtual reality. The use of telephone 
support from the medical team was consistently found to be effective for improving medication 
adherence and reducing severity of symptoms and inpatient days. Few studies evaluated the use of 
remote medication telemonitoring, VR, online self-management and hand-held devices, suggesting 
these are novel technologies for managing SMI, although all were found to be effective for 
improving some psychosocial and behavioural outcomes. Patient preferences should be assessed 
and accommodated, as some may prefer traditional methods of delivery with healthcare staff over 
computer-based methods. Given the poor quality of all but five of the included trials and that few 
studies have evaluated the acceptability and cost-effectiveness of using technology to support 
people with SMI, further studies are needed to establish the potential benefits in these areas.
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